慢性阻塞性肺疾病合并肺栓塞的评估及处置

Evaluation and management of chronic obstructive pulmonary disease complicated with pulmonary embolism

慢性阻塞性肺疾病急性加重(AECOPD)是肺栓塞(PE)的独立危险因素,同时,AECOPD合并PE也导致患者住院时间延长和病死率增加。由于PE与AECOPD的临床表现非常相似,极易造成AECOPD合并PE患者的漏诊和误诊,从而影响患者的治疗及预后,2020年GOLD指南强调指出,PE是AECOPD主要鉴别诊断之一。因此,临床医生需要正确认识并有效评估和治疗AECOPD合并PE的患者,早期和规范诊治具有重要的临床意义。文章将阐述AECOPD合并PE的评估和处置流程。

Acute exacerbation of chronic obstructive pulmonary disease(AECOPD)is an independent risk factor for pulmonary thromboembolism(PE).Meanwhile,AECOPD combined PE also leads to prolonged hospitalization and increased mortality.Since the clinical manifestations of PE are very similar to AECOPD and can easily cause missed diagnosis and misdiagnosis of patients with AECOPD complicated PE,thus affecting the treatment and prognosis of patients,the 2020 GOLD guide emphasizes that PE is one of the main differential diagnoses.Therefore,clinicians should correctly understand,effectively evaluate and manage AECOPD patients combined with PE.Early and standardized diagnosis and treatment has important clinical significance.This paper will discuss the evaluation and management strategy of AECOPD combined PE.